MaxCyte, Inc.MXCTNASDAQ
Loading
Operating Income Growth AcceleratingAccelerating
Percentile Rank90
3Y CAGR+29.8%
5Y CAGR+216.5%
Studio
Year-over-Year Change

Year-over-year operating income growth rate

3Y CAGR
+29.8%/yr
Quarterly compound
5Y CAGR
+216.5%/yr
Recent deceleration
Percentile
P90
Near historical high
vs 5Y Ago
317.7x
Strong expansion
Streak
1 qtr
Consecutive growthAccelerating
PeriodValue
Q3 202525.69%
Q2 2025-15.71%
Q1 20254.70%
Q4 20248.20%
Q3 2024-17.42%
Q2 20242.50%
Q1 2024-51.62%
Q4 202341.98%
Q3 2023-6.73%
Q2 20230.80%
Q1 2023-95.22%
Q4 202212.47%
Q3 202211.75%
Q2 2022-110.12%
Q1 202216.07%
Q4 2021-102.84%
Q3 202144.70%
Q2 202130.69%
Q1 2021-167.61%
Q4 202016.21%
Q3 20200.08%
Q2 20204.81%
Q1 2020-72.67%
Q4 20190.00%
Q3 201961.36%
Q2 20190.00%
Q1 2019-127.40%
Q4 20180.00%
Q3 201812.16%
Q2 20180.00%
Q1 201815.48%
Q4 20170.00%
Q3 2017-33.15%
Q2 20170.00%
Q1 2017-125.41%
Q4 20160.00%
Q3 2016-85.05%
Q2 20160.00%
Q1 2016-453.86%
Q4 20150.00%